Navigation Links
Dendreon Announces Presentation of Data at the American Association of Cancer Research Annual Meeting
Date:4/6/2011

SEATTLE, April 6, 2011 /PRNewswire/ -- Dendreon Corporation (Nasdaq: DNDN) today announced the following data presentations taking place at the American Association of Cancer Research (AACR) 102nd Annual Meeting 2011 in Orlando, Florida:

  • Wednesday, April 6, 2011, 8:00 a.m. - 12:00 p.m. ET.  "B lymphocytes are activated during the course of sipuleucel-T treatment, leading to an antigen-specific humoral response."  Poster presentation.
  • Wednesday, April 6, 2011, 8:00 a.m. - 12:00 p.m. ET.  "Evidence of T lymphocyte activation following sipuleucel-T treatment."  Poster presentation.

About Dendreon

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics.  The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response.  Dendreon's first autologous cellular immunotherapy product, PROVENGE® (sipuleucel-T), was approved by the FDA in April 2010.  Dendreon is also developing an orally-available small molecule that targets TRPM8 that could be applicable to multiple types of cancer.  The Company is headquartered in Seattle, Washington and has manufacturing facilities in New Jersey, Georgia and California.  Dendreon is traded on the Nasdaq Global Market under the symbol DNDN.  For more information about the Company and its programs, visit http://www.dendreon.com/.


'/>"/>
SOURCE Dendreon Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Dendreon Announces Webcast Presentations at Upcoming Conferences
2. Dendreon Expands Launch of PROVENGE
3. Dendreon Announces Exercise and Closing of Overallotment Option
4. Dendreon Announces Offering of $500 Million Convertible Senior Notes Due 2016
5. Dendreon Announces Webcast Presentation at J.P. Morgan Healthcare Conference
6. Dendreon Announces Presentation of PROVENGE Data at the American Society of Hematology and the Society of Urologic Oncology Annual Meetings
7. Dendreon Announces Webcast Presentation at Credit Suisse 2010 Health Care Conference
8. Dendreon Reports Third Quarter 2010 Financial Results
9. Dendreon Announces Presentation of PROVENGE Data at the 25th International Society for Biological Therapy of Cancer Annual Meeting
10. Dendreon Statement on CMS National Coverage Analysis
11. Dendreon Announces Presentation of PROVENGE Data at the American Urological Association Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... 2017 The Rebound mobile app is poised to ... the tide of prescription drug addiction. The app empowers users ... and stepping down their dosage in a safe, controlled manner ... 2017; the first 100,000 people to sign up will enjoy ... ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium ... Master File solutions, today—from the IQPC Trial Master ... , NL)—announced that EastHORN Clinical Services has ... clinical programs and TMF management. EastHORN, a leading ... eTMF platform to increase transparency to enable greater ...
(Date:9/19/2017)... HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform ... leadership team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led ...
Breaking Medicine Technology:
(Date:10/13/2017)... , ... October 13, 2017 , ... As health professionals ... known as “patient engagement.” The patient is doing more than filling out a survey; ... , “There is an increasing emphasis in health care and research on the importance ...
(Date:10/13/2017)... ... , ... PurhealthRX , a leading Health and Nutrition Company, is announcing ... full spectrum CBD oil will revolutionize the rapidly growing CBD market by reducing the ... incorporated into liquid products, while reducing costs to end users. , The team of ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that ... insurance companies have a waiver for care if the client has a cognitive impairment ... family pays for care, is often waived, so the benefits from their insurance start ...
(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the ... “America On The Brink” is the creation of published author, William Nowers. Captain ... As a WWII veteran, he spent thirty years in the Navy. Following his ...
Breaking Medicine News(10 mins):